Neurochemistry International

Neurochemistry International is a journal published by Elsevier since 1980 that reports research in neurochemistry, with a 2025 Journal Impact Factor of 5.5.《国际神经化学》（Neurochemistry International）由（Elsevier）出版，1980 年创办，发表神经化学领域的研究，2025 年影响因子为 5.5。

Scope

• The journal publishes original articles and timely reviews across neurochemistry.本刊发表神经化学领域的原创论文与及时综述。
• Molecular and cellular neurochemistry form the journal's core subject matter.分子与细胞神经化学是本刊的核心内容。
• Neuropharmacology and the genetic aspects of central nervous system function are covered.神经药理学以及中枢神经系统功能的遗传学均有收录。
• Neuroimmunology and the interactions between the nervous and immune systems are published.神经免疫学以及神经与免疫系统的相互作用均予发表。
• Energy metabolism in the brain, including mitochondrial function, is treated at length.脑内能量代谢，包括线粒体功能，受到重点讨论。
• Neurotransmitters, receptors and their signalling pathways are central to many papers.神经递质、受体及其信号通路是许多论文的核心。
• The neurochemistry of neurological and psychiatric disorders of the central nervous system is within scope.中枢神经系统神经与精神疾病的神经化学均在其范围之内。

History

• Neurochemistry International was established in 1980 as a journal devoted to the rapid publication of research in neurochemistry.《国际神经化学》创办于 1980 年，其宗旨是快速发表神经化学研究。
• It was published by Pergamon Press and is now issued by Elsevier.本刊原由（Pergamon Press）出版，现由（Elsevier）发行。
• It appears in about ten issues a year and has long been a venue for work on neurotransmitter systems and brain metabolism.本刊每年约出版十期，长期是神经递质系统与脑代谢研究的发表园地。
• Michael Robinson of the Children's Hospital of Philadelphia served as editor-in-chief for many years.费城儿童医院的 Michael Robinson 担任主编多年。
• Keiji Wada of the National Center of Neurology and Psychiatry in Tokyo is now listed as editor-in-chief.目前期刊页所列主编为东京（National Center of Neurology and Psychiatry）的 Keiji Wada。
• Its impact factor stood at 3.994 in 2018, 4.297 in 2021 and 5.5 in 2025.其影响因子在 2018 年为 3.994，2021 年为 4.297，2025 年为 5.5。

Editors

• Keiji Wada of the National Center of Neurology and Psychiatry in Tokyo is the editor-in-chief.东京（National Center of Neurology and Psychiatry）的 Keiji Wada 担任主编。
• The editorial board covers molecular neurochemistry, neuropharmacology, neuroimmunology and the neurochemistry of disease.编委会覆盖分子神经化学、神经药理学、神经免疫学与疾病神经化学等方向。
• Manuscripts are peer reviewed, and the journal publishes original research papers and review articles.稿件经同行评审，本刊发表原创研究论文与综述。
• The journal operates a hybrid model, so authors may publish open access on payment of a charge.本刊采用混合模式，作者可付费选择开放获取发表。
• Rapid publication remains part of its stated mission, and articles are released online ahead of the printed issue.快速发表仍是其公开宗旨的一部分，文章会先于纸质期次在线发布。
• Special issues are organised around themes such as neurodegeneration and brain energy metabolism.专刊围绕神经退行与脑能量代谢等主题组织。